| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.1B | $5.7B | $5.3B | $5.1B | $4.9B | $1.1B | $0.9B | $0.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.6B | $1.5B | $1.4B | $1.3B | $1.3B | $1.3B | $2.0B | $1.2B |
| Operating Income | $1.1B | $1.0B | $0.9B | $1.1B | $1.1B | $0.2B | $0.0B | $0.0B |
| Net Income | $0.7B | $0.6B | $0.5B | $0.7B | $0.7B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $5.36 | $4.88 | $4.44 | $5.69 | $6.11 | $0.61 | $0.08 | $0.21 |
| EPS (Diluted) | $5.32 | $4.84 | $4.40 | $5.65 | $6.02 | $0.61 | $0.07 | $0.21 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.9B | $11.8B | $12.3B | $11.5B | $11.0B | $9.6B | $7.9B | $7.2B |
| Current Assets | $1.4B | $1.4B | $1.4B | $1.4B | $1.1B | $2.5B | $1.2B | $0.9B |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.3B | $0.2B | $1.7B | $0.4B | $0.2B |
| Total Liabilities | $7.1B | $6.8B | $7.6B | $7.6B | $7.4B | $6.4B | $5.3B | $4.0B |
| Current Liabilities | $2.3B | $1.8B | $2.0B | $2.0B | $2.3B | $2.5B | $1.4B | $0.8B |
| Stockholders' Equity | $4.6B | $4.8B | $4.5B | $4.0B | $3.6B | $3.2B | $2.6B | $3.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $1.3B | $1.1B | $0.8B | $1.3B | $0.9B | $0.3B | $0.7B |
| Investing Cash Flow | $-0.6B | $-0.5B | $-0.9B | $-1.0B | $-3.4B | $-0.5B | $-0.7B | $-0.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.1B | $-0.8B | $-0.3B | $0.3B | $0.6B | $0.8B | $0.6B | $-0.3B |